Astellas, Poseida Therapeutics ink research collaboration & license agreement to develop allogeneic cell therapies in ...
Astellas Pharma Inc, a pharmaceutical company conducting business in more than 70 countries around the world, and Poseida Therapeutics, a clinical-stage biopharmaceutical company advancing differentiated cell therapies and genetic medicines , announced …